ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Search results for: fracture

I Am an Advocate

Susan Leigh  |  

Earlier this year, I was privileged to be part of the ACR’s Advocates for Arthritis advocacy visit. My rheumatologist recommended that I apply for the event, and I was thrilled when I was accepted, even though my acceptance wasn’t necessarily competitive (I was the only patient representative from Delaware).

RheumPAC: One Year, One Contribution, One Opportunity

  |  

Responders to the recent ACR membership survey emphasized the importance of political advocacy for their practices and institutions. RheumPAC, the ACR’s political action committee, was created in February 2007 to focus on the legislative issues affecting the rheumatology community.

Glucocorticoid-Induced Osteoporosis

  |  

Osteoporosis is a condition of weak bone caused by a loss of bone mass and a change in bone structure. Glucocorticoid-induced osteoporosis is a form of osteoporosis caused by taking glucocorticoid medications, such as prednisone (Deltasone, Orasone, etc.), prednisolone (Prelone), dexamethasone (Decadron, Hexadrol), and cortisone (Cortone Acetate). These medications are used to help control many rheumatic diseases, including RA, systemic lupus erythematosus, and polymyalgia rheumatica.

American College of Rheumatology (ACR) on Capitol Hill

  |  

“By tomorrow night, there will be so many more people on Capitol Hill who know—and are sensitive to—rheumatology and the issues that impact you and your patients. There is no substitute for what you are doing,” says Martha M. Kendrick, a partner at Patton Boggs, LLP, the ACR’s lobbying firm. This is what she told the physician, health professional, and patient participants of the ACR’s 2008 “Advocates for Arthritis” advocacy event—termed a fly-in—before they took their personal stories to the lawmakers on Capitol Hill.